Immune Globulin IV comment watch save
Breastfeeding

  • TRADE NAMES: Allerglobuline; Baygam; Beriglobulin; Citax; Endobulin; Gamafine; Gamastan; Gamimune (Bayer); Gamma 16; Gammabulin; Gammagard (Baxter); Gammar PIV (ZLB Behring); Gammer-IV; Gammonayiv; Gamunex (Bayer); IG Gamma; IGIM; Interglobin; IV Globulin-S; Iveegam (Baxter); Octagam; Panglobulin; Panzyga (Octapharma); Pentaglobin; Polygam S/D; Sandoglobulin; Sandoglobulina; Sandoglobuline; Venoglobulin (Alpha Therapeutics)
  • INDICATIONS: Immunodeficiency in patients unable to produce sufficient amounts of IgG antibodies
  • SYNONYM: IGIV; IVIG; Octagam; intravenous immunoglobulin (IVIg)
  • CLASS: Covid-19 putative drug, Immunomodulator
  • HALF-LIFE: N/A
  • CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
    Live vaccines

Investigated for treating COVID-19.

THROMBOSIS, RENAL DYSFUNCTION and ACUTE RENAL FAILURE

See full prescribing information for complete boxed warning.

Please login to view the rest of this drug profile.

Page last updated 03/04/2025

Symbol key

Incidence

<1% 1‑5% 5‑10% 10‑15% 15‑20% 20‑30% >30%

Seriousness

Hospitalization possible
Life threatening
Fatal

Warnings in other populations

BreastfeedingBreast feeding

GeriatricGeriatric

PediatricPediatric